A polysaccharide active in sargassum and a preparation method and application thereof
By extracting and isolating PEP-W-1, an active polysaccharide from jicama, the problem of gut microbiota regulation in liver fibrosis was solved, achieving protection and regulation of liver fibrosis and showing a significant anti-fibrotic effect.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIV
- Filing Date
- 2026-03-12
- Publication Date
- 2026-06-09
AI Technical Summary
The occurrence and development of liver fibrosis are influenced by a variety of factors. Current technologies are insufficient to effectively regulate the gut microbiota, leading to liver dysfunction and fibrosis progression. There is a lack of effective prevention and treatment strategies.
Active polysaccharides of jicama were extracted and isolated from jicama beans, and prepared into active polysaccharide PEP-W-1 through steps such as thermal extraction, alcohol precipitation, ion exchange chromatography and gel filtration. It is intended for use in regulating the intestinal microbiota and is a potential anti-liver fibrosis drug.
PEP-W-1, an active polysaccharide from jicama, showed a protective effect on the liver in a mouse model of liver fibrosis induced by bile duct ligation, regulating the gut microbiota, alleviating liver fibrosis, improving liver function indicators, and reducing the expression of fibrosis markers.
Smart Images

Figure CN121824798B_ABST